(Stroke. 1996;27:1760-1764.)
© 1996 American Heart Association, Inc.
Articles |
Stroke Severity in Atrial Fibrillation
The Framingham Study
the Department of Neurology, Boston University School of Medicine (H.-J.L., P.A.W., M.K.-H., C.S.K.); the Department of Biostatistics and Epidemiology, Boston University School of Public Health (A.S.B.); the Cardiology Department, Boston University School of Medicine (E.J.B.); the Department of Mathematics, Boston University (R.B.D.); and the Framingham Study, National Heart, Lung, and Blood Institute, Framingham, Mass.
Correspondence to Philip A. Wolf, MD, Department of Neurology, Boston University School of Medicine, 80 E Concord St, B-608, Boston, MA 02118. E-mail pawolf@acs.bu.edu.
Background and Purpose Stroke occurring with atrial fibrillation (AF) is more likely to be fatal or more severe than non-AF stroke based on clinical series, but data from prospective epidemiological studies are sparse and inconsistent.
Methods Over 40-year follow-up of the original 5070 Framingham cohort, 501 initial ischemic strokes, including 103 with AF, were analyzed. Stroke severity was rated as none, mild, moderate, severe, or fatal. Since 1981, functional status indicated by the Barthel index has been evaluated acutely and at 3, 6, and 12 months. Severity and functional status of AF strokes were compared with non-AF strokes using 
2 test and Student's t test. Thirty-day mortality was assessed by logistic regression analyses.
Results AF was associated with increased stroke severity (P=.048). Thirty-day mortality was greater in AF strokes than in non-AF strokes (25% versus 14%). The multivariate-adjusted odds ratio for 30-day mortality for AF subjects was 1.84 (95% confidence interval, 1.04 to 3.27). Since 1981, follow-up was available for 150 initial ischemic strokes, including 30 with AF. Compared with the non-AF group, the AF group had poorer survival and more recurrences during 1 year of follow-up. The AF subjects had lower mean Barthel index scores acutely (29.6 versus 58.6, P<.001) and at 3 months (P=.005), 6 months (P=.003), and 12 months (P=.130) after stroke among survivors.
Conclusions Ischemic stroke associated with AF was nearly twice as likely to be fatal as non-AF stroke. Recurrence was more frequent, and functional deficits were more likely to be severe among survivors. Since stroke is usually the initial manifestation of embolism in AF, prevention is critical to reducing disability and mortality.
Key Words: atrial fibrillation • stroke outcome • risk factors • mortality • disability evaluation
This article has been cited by other articles:
 |
|
 |
|
  D. R. Holmes Jr and R. S. Schwartz Left Atrial Appendage Occlusion Eliminates the Need for Warfarin Circulation, November 10, 2009; 120(19): 1919 - 1926. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation' Europace, July 1, 2009; 11(7): 860 - 885. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. John Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF' Eur. Heart J., June 17, 2009; (2009) ehp235v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Romero, J. Morris, and A. Pikula Review: Stroke prevention: modifying risk factors Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 287 - 303. [Abstract] [PDF]
|
|
|
|
 |
|
 D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Garwood and T. L Corbett Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls Ann. Pharmacother., April 1, 2008; 42(4): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Taimur and S. Hussaini Atrial fibrillation in a commercial diver Occup. Med., March 1, 2008; 58(2): 144 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Weintraub Predicting Thromboembolism and Selecting Patients for Anticoagulant Therapy in Atrial Fibrillation J. Am. Coll. Cardiol., February 26, 2008; 51(8): 816 - 817. [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Slot, E. Berge, P. Dorman, S. Lewis, M. Dennis, P. Sandercock, and on behalf of the Oxfordshire Community Stroke Proj Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies BMJ, February 16, 2008; 336(7640): 376 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G.G. Turpie New oral anticoagulants in atrial fibrillation Eur. Heart J., January 2, 2008; 29(2): 155 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Nutescu ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291. [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Olsen, R. H. B. Christensen, L. P. Kammersgaard, and K. K. Andersen Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality: Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study Stroke, October 1, 2007; 38(10): 2646 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C P M van Weert Diagnosing atrial fibrillation in general practice BMJ, August 25, 2007; 335(7616): 355 - 356. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Carter, A. J. Catto, M. W. Mansfield, J. M. Bamford, and P. J. Grant Predictive Variables for Mortality After Acute Ischemic Stroke Stroke, June 1, 2007; 38(6): 1873 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hylek, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation Circulation, May 29, 2007; 115(21): 2689 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rastas, A. Verkkoniemi, T. Polvikoski, K. Juva, L. Niinisto, K. Mattila, E. Lansimies, T. Pirttila, and R. Sulkava Atrial Fibrillation, Stroke, and Cognition: A Longitudinal Population-Based Study of People Aged 85 and Older Stroke, May 1, 2007; 38(5): 1454 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Akins, H. A. Feldman, R. G. Zoble, D. Newman, S. G. Spitzer, H.-C. Diener, and G. W. Albers Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials Stroke, March 1, 2007; 38(3): 874 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Somerfield, P. A. Barber, N. E. Anderson, A. Kumar, D. Spriggs, A. Charleston, P. Bennett, Y. Baker, and L. Ross Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy Stroke, May 1, 2006; 37(5): 1217 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Hylek, J. D'Antonio, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation Stroke, April 1, 2006; 37(4): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Bateman, H. C. Schumacher, B. Boden-Albala, M. F. Berman, J.P. Mohr, R. L. Sacco, and J. Pile-Spellman Factors Associated With In-Hospital Mortality After Administration of Thrombolysis in Acute Ischemic Stroke Patients: An Analysis of the Nationwide Inpatient Sample 1999 to 2002 Stroke, February 1, 2006; 37(2): 440 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bushi, Y. Grad, S. Einav, O. Yodfat, B. Nishri, and D. Tanne Hemodynamic Evaluation of Embolic Trajectory in an Arterial Bifurcation: An In-Vitro Experimental Model Stroke, December 1, 2005; 36(12): 2696 - 2700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, J. B. Seward, K. R. Bailey, T. Iwasaka, and T. S.M. Tsang Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000: Report of a Community-Based Study Stroke, November 1, 2005; 36(11): 2362 - 2366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Meijer, J van Limbeek, G Peusens, M Rulkens, K Dankoor, M Vermeulen, and R J de Haan The Stroke unit Discharge Guideline, a prognostic framework for the discharge outcome from the hospital stroke unit. A prospective cohort study Clinical Rehabilitation, July 1, 2005; 19(7): 770 - 778. [Abstract] [PDF]
|
|
|
|
|
|
C. Marini, F. De Santis, S. Sacco, T. Russo, L. Olivieri, R. Totaro, and A. Carolei Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study Stroke, June 1, 2005; 36(6): 1115 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Kimura, K Minematsu, T Yamaguchi, and for the Japan Multicenter Stroke Investigators' Co Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 679 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Emmerich, J.-Y. Le Heuzey, P. M.W. Bath, and S. J. Connolly Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practice Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C28 - C33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S.J. Miller, M. F. Drummond, L. K. Langkilde, J. J.V. McMurray, and M. Ogren Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation Eur. Heart J. Suppl., May 1, 2005; 7(suppl_C): C41 - C54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S.J. Miller, F. L. Andersson, and L. Kalra Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated? Stroke, February 1, 2005; 36(2): 360 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens Anticoagulation in atrial fibrillation and flutter Europace, January 1, 2005; 7(5): 492 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Marshall, A. R. Levy, H. Vidaillet, E. Fenwick, A. Slee, G. Blackhouse, H. L. Greene, D. G. Wyse, G. Nichol, B. J. O'Brien, et al. Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation Ann Intern Med, November 2, 2004; 141(9): 653 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Thijs More bad news about atrial fibrillation Eur. Heart J., October 1, 2004; 25(19): 1670 - 1671. [Full Text] [PDF]
|
|
|
|
|
|
C. Steger, A. Pratter, M. Martinek-Bregel, M. Avanzini, A. Valentin, J. Slany, and C. Stollberger Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur. Heart J., October 1, 2004; 25(19): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Singer, G. W. Albers, J. E. Dalen, A. S. Go, J. L. Halperin, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 429S - 456S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tanaka, Y. Nakayama, Y. Maeda, T. Nishioka, M. Shirakawa, and K. Tsumura Electrocardiographic Q-waves as a predictor of mortality in patients with cerebral infarction Neurology, May 25, 2004; 62(10): 1818 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Dowd Anticoagulation in the Elderly Journal of Pharmacy Practice, April 1, 2004; 17(2): 94 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 E. M. Hylek, A. S. Go, Y. Chang, N. G. Jensvold, L. E. Henault, J. V. Selby, and D. E. Singer Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation N. Engl. J. Med., September 11, 2003; 349(11): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Roquer, A. R. Campello, and M. Gomis Sex Differences in First-Ever Acute Stroke Stroke, July 1, 2003; 34(7): 1581 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-E. Megherbi, C. Milan, D. Minier, G. Couvreur, G.-V. Osseby, K. Tilling, A. Di Carlo, D. Inzitari, C. D.A. Wolfe, T. Moreau, et al. Association Between Diabetes and Stroke Subtype on Survival and Functional Outcome 3 Months After Stroke: Data From the European BIOMED Stroke Project Stroke, March 1, 2003; 34(3): 688 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Meijer, D S Ihnenfeldt, I J. de Groot, J van Limbeek, M Vermeulen, and R J de Haan Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature Clinical Rehabilitation, February 1, 2003; 17(2): 119 - 129. [Abstract] [PDF]
|
|
|
|
 |
|
 S K S Lairikyengbam, M H Anderson, and A G Davies Present treatment options for atrial fibrillation Postgrad. Med. J., February 1, 2003; 79(928): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Appelros, I. Nydevik, and M. Viitanen Poor Outcome After First-Ever Stroke: Predictors for Death, Dependency, and Recurrent Stroke Within the First Year Stroke, January 1, 2003; 34(1): 122 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Appelros, I. Nydevik, A. Seiger, and A. Terent Predictors of Severe Stroke: Influence of Preexisting Dementia and Cardiac Disorders Stroke, October 1, 2002; 33(10): 2357 - 2362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.C. Anderson, L.J. Kappelle, M. Eliasziw, V.L. Babikian, L.A. Pearce, H.J.M. Barnett, and J. Blakely Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis * Editorial Comment Stroke, August 1, 2002; 33(8): 1963 - 1968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tilling, J. A.C. Sterne, A. G. Rudd, T. A. Glass, R. J. Wityk, and C. D.A. Wolfe A New Method for Predicting Recovery After Stroke Stroke, December 1, 2001; 32(12): 2867 - 2873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. McCormick, J. H. Gurwitz, R. J. Goldberg, R. Becker, J. P. Tate, A. Elwell, and M. J. Radford Prevalence and Quality of Warfarin Use for Patients With Atrial Fibrillation in the Long-term Care Setting Arch Intern Med, November 12, 2001; 161(20): 2458 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Grau, C. Weimar, F. Buggle, A. Heinrich, M. Goertler, S. Neumaier, J. Glahn, T. Brandt, W. Hacke, and H.-C. Diener Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank Stroke, November 1, 2001; 32(11): 2559 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D Douketis Review: warfarin prevents stroke in non-rheumatic atrial fibrillation but has a higher risk for haemorrhage than other agents Evid. Based Med., September 1, 2001; 6(5): 150 - 150. [Full Text] [PDF]
|
|
|
|
|
|
G. Y.H. Lip, E. K.H. Tan, C. K.Y. Lau, and S. Kamath Diurnal Variation in Stroke Onset in Atrial Fibrillation Stroke, June 1, 2001; 32(6): 1443 - 1448. [Full Text] [PDF]
|
|
|
|
|
|
W.T. Longstreth Jr., C. Bernick, A. Fitzpatrick, M. Cushman, L. Knepper, J. Lima, and C.D. Furberg Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study Neurology, February 13, 2001; 56(3): 368 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lamassa, A. Di Carlo, G. Pracucci, A. M. Basile, G. Trefoloni, P. Vanni, S. Spolveri, M. C. Baruffi, G. Landini, A. Ghetti, et al. Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe : Data From a Multicenter Multinational Hospital-Based Registry (The European Community Stroke Project) Stroke, February 1, 2001; 32(2): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Babikian and L. R. Caplan Brain embolism is a dynamic process with variable characteristics Neurology, February 22, 2000; 54(4): 797 - 801. [Full Text] [PDF]
|
|
|
|
|
|
W. N. Kernan, C. M. Viscoli, L. M. Brass, R. W. Makuch, P. M. Sarrel, R. S. Roberts, M. Gent, P. Rothwell, R. L. Sacco, R.-C. Liu, et al. The Stroke Prognosis Instrument II (SPI-II) : A Clinical Prediction Instrument for Patients With Transient Ischemia and Nondisabling Ischemic Stroke Stroke, February 1, 2000; 31(2): 456 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.Y.H. Lip Atrial fibrillation and mortality Eur. Heart J., November 1, 1999; 20(21): 1525 - 1527. [PDF]
|
|
|
|
 |
|
 D Deplanque, F Corea, C Arquizan, L Parnetti, J L Mas, V Gallai, D Leys, and the SAFE I Study Investigators Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? Heart, November 1, 1999; 82(5): 563 - 569. [Abstract] [Full Text]
|
|
|
|
|
|
K. S. Wong Risk Factors for Early Death in Acute Ischemic Stroke and Intracerebral Hemorrhage : A Prospective Hospital-Based Study in Asia Stroke, November 1, 1999; 30(11): 2326 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere Idiopathic atrial fibrillation as a risk factor for mortality.The Paris Prospective Study I Eur. Heart J., June 2, 1999; 20(12): 896 - 899. [Abstract] [PDF]
|
|
|
|
|
|
A. M. Carter, A. J. Catto, and P. J. Grant Association of the {alpha}-Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation Circulation, May 11, 1999; 99(18): 2423 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Catherwood, W. D. Fitzpatrick, M. L. Greenberg, P. T. Holzberger, D. J. Malenka, B. R. Gerling, and J. D. Birkmeyer Cost-Effectiveness of Cardioversion and Antiarrhythmic Therapy in Nonvalvular Atrial Fibrillation Ann Intern Med, April 20, 1999; 130(8): 625 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. D. Scinto, D. Mathur, and M. Radford Warfarin Use Following Ischemic Stroke Among Medicare Patients With Atrial Fibrillation Arch Intern Med, October 26, 1998; 158(19): 2093 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Moroney, E. Bagiella, M. C. Paik, R. L. Sacco, and D. W. Desmond Risk Factors for Early Recurrence After Ischemic Stroke : The Role of Stroke Syndrome and Subtype Stroke, October 1, 1998; 29(10): 2118 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Cheung, D. E. Singer, R. McBride, R. G. Hart, and J. L. Halperin Patients With Atrial Fibrillation at Low Risk of Stroke JAMA, September 9, 1998; 280(10): 882 - 883. [Full Text] [PDF]
|
|
|
|
|
|
E. J. Benjamin, P. A. Wolf, R. B. D'Agostino, H. Silbershatz, W. B. Kannel, and D. Levy Impact of Atrial Fibrillation on the Risk of Death : The Framingham Heart Study Circulation, September 8, 1998; 98(10): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The SPAF III Writing Committee for the Stroke Prev Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study JAMA, April 22, 1998; 279(16): 1273 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Wolf, J. B. Mitchell, C. S. Baker, W. B. Kannel, and R. B. D'Agostino Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs Arch Intern Med, February 9, 1998; 158(3): 229 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Prencipe, F. Culasso, M. Rasura, A. Anzini, M. Beccia, M. Cao, F. Giubilei, and C. Fieschi Long-term Prognosis After a Minor Stroke : 10-Year Mortality and Major Stroke Recurrence Rates in a Hospital-Based Cohort Stroke, January 1, 1998; 29(1): 126 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brass, H. M. Krumholz, J. M. Scinto, and M. Radford Warfarin Use Among Patients With Atrial Fibrillation Stroke, December 1, 1997; 28(12): 2382 - 2389. [Abstract] [Full Text]
|
|
|
|
|
|
P.-K. Yip, J.-S. Jeng, T.-K. Lee, Y.-C. Chang, Z.-S. Huang, S.-K. Ng, and R.-C. Chen Subtypes of Ischemic Stroke : A Hospital-Based Stroke Registry in Taiwan (SCAN-IV) Stroke, December 1, 1997; 28(12): 2507 - 2512. [Abstract] [Full Text]
|
|